Page last updated: 2024-11-04

stearic acid and Diabetes Mellitus, Type 1

stearic acid has been researched along with Diabetes Mellitus, Type 1 in 3 studies

octadecanoic acid : A C18 straight-chain saturated fatty acid component of many animal and vegetable lipids. As well as in the diet, it is used in hardening soaps, softening plastics and in making cosmetics, candles and plastics.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to study the effect of adding polyunsaturated fatty acid (PUFA) n-3 or placebo (containing oleic acid) to a combined statin-fibrate treatment on plasma lipoproteins, lipoperoxidation, glucose homeostasis, total homocysteine (tHcy) and microalbuminuria (MA) in patients with diabetic dyslipidemia (DDL)."5.12N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. ( Písaríková, A; Stanková, B; Tvrzická, E; Vecka, M; Zák, A; Zeman, M, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zeman, M1
Zák, A1
Vecka, M1
Tvrzická, E1
Písaríková, A1
Stanková, B1
Suresh, Y1
Das, UN1
Taylor, AJ1
Jennings, PE1
Barnett, AH1
Pandov, HI1
Lawson, N1

Trials

1 trial available for stearic acid and Diabetes Mellitus, Type 1

ArticleYear
N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.
    The Journal of nutritional biochemistry, 2006, Volume: 17, Issue:6

    Topics: Adult; Albuminuria; Cholesterol Esters; Clofibric Acid; Diabetes Mellitus, Type 1; Dietary Supplemen

2006

Other Studies

2 other studies available for stearic acid and Diabetes Mellitus, Type 1

ArticleYear
Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus.
    Prostaglandins, leukotrienes, and essential fatty acids, 2006, Volume: 74, Issue:3

    Topics: Alloxan; Animals; Arachidonic Acid; Blood Glucose; Body Weight; Catalase; Ceruloplasmin; Diabetes Me

2006
An alternative explanation for the changes in erythrocyte fatty acids observed in diabetes mellitus.
    Clinical chemistry, 1987, Volume: 33, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arachidonic Acid; Arachidonic Acids; Blood Glucose; Chro

1987